# Vaxcyte, Inc.: filings

PCVX · Nasdaq · CIK 1649094 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pcvx.md) · [Financials](/companies/pcvx/financials.md) · [Filings](/companies/pcvx/filings.md) · [Insiders](/companies/pcvx/insiders.md)

## Reports and events: 101 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 383, 144 122, 8-K 68, 3 32, SC 13G/A 25, 10-Q 19, 424B5 18, SCHEDULE 13G/A 16, SC 13G 10, S-8 7, 10-K 6, DEF 14A 6, DEFA14A 6, UPLOAD 5, ARS 4, CORRESP 4, D 4, 4/A 3, S-3ASR 3, 144/A 2, DRS/A 2, DRSLTR 2, SCHEDULE 13G 2, 305B2 1, 424B4 1, 8-A12B 1, CERT 1, DRS 1, EFFECT 1, FWP 1, PRE 14A 1, S-1 1, S-1/A 1, S-1MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-09 | 20:42 ET | [8-K](/filings/0001193125-26-419174.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-419174 |
| 2026-10-05 | 12:01 ET | [8-K](/filings/0001193125-26-413168.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-413168 |
| 2026-09-03 | 20:18 ET | [8-K](/filings/0001649094-26-000045.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001649094-26-000045 |
| 2026-08-05 | 20:13 ET | [10-Q](/filings/0001649094-26-000043.md) | Quarterly report, period 2026-06-30 | 0001649094-26-000043 |
| 2026-08-05 | 20:07 ET | [8-K](/filings/0001649094-26-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001649094-26-000041 |
| 2026-07-15 | 20:05 ET | [8-K](/filings/0001649094-26-000030.md) | 5.02 Departure or appointment of officers or directors | 0001649094-26-000030 |
| 2026-06-23 | 20:09 ET | [8-K](/filings/0001649094-26-000026.md) | 5.02 Departure or appointment of officers or directors | 0001649094-26-000026 |
| 2026-06-16 | 20:12 ET | [8-K](/filings/0001649094-26-000021.md) | 5.07 Shareholder vote results | 0001649094-26-000021 |
| 2026-05-06 | 20:12 ET | [10-Q](/filings/0001649094-26-000017.md) | Quarterly report, period 2026-03-31 | 0001649094-26-000017 |
| 2026-05-06 | 20:08 ET | [8-K](/filings/0001649094-26-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001649094-26-000015 |
| 2026-04-23 | 20:06 ET | [DEF 14A](/filings/0001193125-26-173672.md) | Proxy statement, period 2026-06-15 | 0001193125-26-173672 |
| 2026-02-24 | 22:21 ET | [8-K](/filings/0001193125-26-067546.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-067546 |
| 2026-02-24 | 21:37 ET | [10-K](/filings/0001649094-26-000007.md) | Annual report, period 2025-12-31 | 0001649094-26-000007 |
| 2026-02-24 | 21:14 ET | [8-K](/filings/0001649094-26-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001649094-26-000005 |
| 2026-02-02 | 21:01 ET | [8-K](/filings/0001193125-26-033578.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-033578 |
| 2025-12-19 | 21:11 ET | [8-K](/filings/0001649094-25-000116.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001649094-25-000116 |
| 2025-11-04 | 21:13 ET | [10-Q](/filings/0001649094-25-000114.md) | Quarterly report, period 2025-09-30 | 0001649094-25-000114 |
| 2025-11-04 | 21:08 ET | [8-K](/filings/0001649094-25-000112.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001649094-25-000112 |
| 2025-09-30 | 13:06 ET | [8-K](/filings/0001649094-25-000102.md) | 1.01 Entry into a material agreement | 0001649094-25-000102 |
| 2025-08-06 | 20:17 ET | [10-Q](/filings/0001649094-25-000098.md) | Quarterly report, period 2025-06-30 | 0001649094-25-000098 |
| 2025-08-06 | 20:08 ET | [8-K](/filings/0001649094-25-000096.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001649094-25-000096 |
| 2025-06-17 | 20:29 ET | [8-K](/filings/0001649094-25-000084.md) | 5.07 Shareholder vote results | 0001649094-25-000084 |
| 2025-05-07 | 20:23 ET | [10-Q](/filings/0001649094-25-000074.md) | Quarterly report, period 2025-03-31 | 0001649094-25-000074 |
| 2025-05-07 | 20:03 ET | [8-K](/filings/0001649094-25-000073.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001649094-25-000073 |
| 2025-05-01 | 12:16 ET | [8-K](/filings/0001649094-25-000057.md) | 5.02 Departure or appointment of officers or directors | 0001649094-25-000057 |
| 2025-04-28 | 20:01 ET | [DEF 14A](/filings/0001193125-25-100425.md) | Proxy statement, period 2025-06-12 | 0001193125-25-100425 |
| 2025-03-31 | 12:36 ET | [8-K](/filings/0001193125-25-067901.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-067901 |
| 2025-02-25 | 21:11 ET | [10-K](/filings/0001649094-25-000028.md) | Annual report, period 2024-12-31 | 0001649094-25-000028 |
| 2025-02-25 | 21:04 ET | [8-K](/filings/0001649094-25-000027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001649094-25-000027 |
| 2024-11-21 | 21:10 ET | [8-K](/filings/0001193125-24-263406.md) | 1.01 Entry into a material agreement; 8.01 Other events | 0001193125-24-263406 |
| 2024-11-05 | 21:05 ET | [10-Q](/filings/0001649094-24-000097.md) | Quarterly report, period 2024-09-30 | 0001649094-24-000097 |
| 2024-11-05 | 21:03 ET | [8-K](/filings/0001649094-24-000096.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001649094-24-000096 |
| 2024-09-06 | 12:00 ET | [8-K](/filings/0001193125-24-214711.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-214711 |
| 2024-09-03 | 12:04 ET | [8-K](/filings/0001193125-24-211572.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-211572 |
| 2024-08-06 | 20:09 ET | [10-Q](/filings/0001649094-24-000052.md) | Quarterly report, period 2024-06-30 | 0001649094-24-000052 |
| 2024-08-06 | 20:07 ET | [8-K](/filings/0001649094-24-000051.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001649094-24-000051 |
| 2024-07-02 | 20:05 ET | [8-K](/filings/0001193125-24-174317.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-174317 |
| 2024-06-10 | 20:19 ET | [8-K](/filings/0001193125-24-158355.md) | 5.07 Shareholder vote results | 0001193125-24-158355 |
| 2024-05-08 | 20:10 ET | [10-Q](/filings/0001628280-24-021677.md) | Quarterly report, period 2024-03-31 | 0001628280-24-021677 |
| 2024-05-08 | 20:08 ET | [8-K](/filings/0001628280-24-021665.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-021665 |
| 2024-04-15 | 20:06 ET | [DEF 14A](/filings/0001193125-24-096192.md) | Proxy statement, period 2024-06-06 | 0001193125-24-096192 |
| 2024-02-27 | 21:12 ET | [10-K](/filings/0000950170-24-021145.md) | Annual report, period 2023-12-31 | 0000950170-24-021145 |
| 2024-02-27 | 21:02 ET | [8-K](/filings/0000950170-24-021081.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021081 |
| 2024-01-31 | 22:19 ET | [8-K](/filings/0001193125-24-021084.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-021084 |
| 2023-11-28 | 13:32 ET | [8-K](/filings/0001193125-23-283769.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-283769 |
| 2023-11-27 | 21:05 ET | [8-K](/filings/0001193125-23-283354.md) | 1.01 Entry into a material agreement | 0001193125-23-283354 |
| 2023-11-06 | 21:11 ET | [10-Q](/filings/0000950170-23-059395.md) | Quarterly report, period 2023-09-30 | 0000950170-23-059395 |
| 2023-11-06 | 21:07 ET | [8-K](/filings/0000950170-23-059386.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-059386 |
| 2023-10-16 | 12:01 ET | [8-K](/filings/0001193125-23-256533.md) | 1.01 Entry into a material agreement | 0001193125-23-256533 |
| 2023-10-04 | 21:15 ET | [8-K](/filings/0001193125-23-250816.md) | 1.01 Entry into a material agreement | 0001193125-23-250816 |

Page 1 of 3. [Older](/companies/pcvx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.